Harbour Biomed IPO: Positive Thoughts in Brief
This Insight includes a brief analysis of Harbour Biomed and its proposed listing on the HKEX. We like the deal at the price range offered.
335 Views
Simcere Pharmaceutical IPO: Valuation Insights
We think that an attractive PEG valuation and solid cornerstone support makes Simcere tempting at the proposed pricing range
468 Views
Asia Short Interest Weekly - Big Jump in Japan Shorts
The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...
293 Views
Last Week in Event SPACE: Jardine Matheson, Vedanta, Cromwell, Cardinal, Taubman, Mediawan
Last Week in Event SPACE ... Jardine Matheson Holdings (JM SP)'s buybacks accelerate, suggesting now is the time to reverse the set-up trade...
412 Views
3SBio: The Frequent Board Turnover Is Just the Tip of the Iceberg of a Larger Governance Issue
3SBio, based in China develops, manufactures, markets and sells biopharmaceuticals. The company owns market-leading biopharmaceuticals franchises...
295 Views